Conference item
CORE: A randomised trial of COventional care versus Radioablation (stereotactic body radiotherapy) for Extracranial oligometastases
- Abstract:
- Stereotactic body radiotherapy (SBRT) is increasingly becoming a key treatment option for patients with oligometastatic disease. However, a lack of randomised data limits interpretation of results from retrospective and prospective cohort studies. Whilst these studies indicate higher rates of local control with acceptable toxicity the true benefit of adding SBRT to standard therapy remains unclear. Potential therapeutic benefit may also vary between tumour sites (underlying tumour biology, natural disease course). CORE investigates whether the addition of SBRT to standard therapy improves patient outcomes in common primary tumour sites where oligometastatic disease is encountered (prostate, breast, NSCLC).
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 101.2KB, Terms of use)
-
- Publisher copy:
- 10.1016/S0169-5002(17)30172-1
Authors
- Publisher:
- Elsevier
- Host title:
- 15th Annual British Thoracic Oncology Group Conference
- Journal:
- 15th Annual British Thoracic Oncology Group Conference More from this journal
- Publication date:
- 2017-02-01
- DOI:
- ISSN:
-
1872-8332 and 0169-5002
- Pubs id:
-
pubs:827072
- UUID:
-
uuid:c6819341-90a9-43ed-9937-7bc9db66c362
- Local pid:
-
pubs:827072
- Source identifiers:
-
827072
- Deposit date:
-
2018-03-19
Terms of use
- Copyright holder:
- Elsevier Ireland Ltd
- Copyright date:
- 2017
- Notes:
- Copyright © 2017 Elsevier Ireland Ltd. All rights reserved.. This is the accepted manuscript version of the article. The final version is available online from Elsevier at: https://dx.doi.org/10.1016/S0169-5002(17)30172-1
If you are the owner of this record, you can report an update to it here: Report update to this record